Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients
about
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risksSurveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology GroupA prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation StudyChildren's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma.Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.Management of Hodgkins Lymphoma: ICMR Consensus Document.The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).Pharmacotherapeutic Management of Pediatric Lymphoma.Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
P2860
Q30248284-E453EFE0-69AB-46E8-A741-E82DB759E4EBQ34640709-4B289C89-63D7-47E1-BB6F-FBB3466AAF20Q36025958-3BCB2695-FA07-47E9-A8DC-53F942D21434Q36248964-6E4CF97D-A743-4CE4-9378-ACD646FEFCEBQ37548240-240C6DFA-759D-473E-8DF8-D3C30447EC6AQ38068839-3BD4FCCB-0BD6-4EE3-80EC-C6E72A712036Q38185983-8C44FD27-EC35-4B5D-B079-B8ABBD28F915Q38684561-CBD4CD7D-D5F7-419C-AEC5-2B345959B0CEQ39208309-6678C746-3FD4-4EA8-8AD5-8A964547CC39Q41265178-951245C2-B985-40F0-89DF-0E02299931CCQ47424276-51162BBC-12BE-4BA9-8DAD-8E0E2F40AA63Q48321203-627EE74B-5D8E-49E4-B3C1-322E957ACB76Q48548248-AC965E96-0E2F-4E02-AACF-D669BE09DABAQ51740308-390685D1-20A5-4B35-8241-72472A3F4B19
P2860
Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@ast
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@en
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@nl
type
label
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@ast
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@en
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@nl
prefLabel
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@ast
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@en
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@nl
P2093
P2860
P356
P1433
P1476
Initial response to salvage th ...... tric Hodgkin lymphoma patients
@en
P2093
Jianrong Wu
John T Sandlund
Larry E Kun
Matthew J Krasin
Melissa M Hudson
Monika L Metzger
Scott C Howard
Sue C Kaste
P2860
P304
P356
10.1002/CNCR.25225
P407
P577
2010-09-01T00:00:00Z